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Infections caused by porcine reproductive and respiratory syndrome virus (PRRSV) have
a severe economic impact on pig production in North America, Europe, and Asia. The
emergence and eventual predominance of PRRS in the 1990s are the likely result of
changes in the pork industry initiated in the late 1970s, which allowed the virus to
occupy a unique niche within a modern commercial production system. PRRSV infection is
responsible for severe clinical disease, but can maintain a life-long subclinical infection, as
well as participate in several polymicrobial syndromes. Current vaccines lessen clinical
signs, but are of limited use for disease control and elimination. The relatively poor
protective immunity following vaccination is a function of the virus’s capacity to generate
a large degree of genetic diversity, combined with several strategies to evade innate
and adaptive immune responses. In 2007, the PRRS Host Genetics consortium (PHGC)
was established to explore the role of host genetics as an avenue for PRRS control.
The PHGC model for PRRS incorporates the experimental infection of large numbers of
growing pigs and has created the opportunity to study experimental PRRSV infection at the
population level. The results show that pigs can be placed into distinct phenotypic groups,
including pigs that show resistance (i.e., low virus load) or pigs that exhibit “tolerance”
to infection. Tolerance was illustrated by pigs that gain weight normally in the face of
a relatively high virus load. Genome-wide association analysis has identified a region on
chromosome 4 (SSC4) correlated with resistance; i.e., lower cumulative virus load within
the first 42 days of infection. The genomic region is near a family of genes involved in
innate immunity. The region is also associated with higher weight gain in challenged pigs,
suggesting that pigs with the resistance alleles don’t seem to simultaneously experience
reduction in growth, i.e., that resistance and tolerance are not antagonistically related.
These results create the opportunity to develop breeding programs that will produce pigs
with increased resistance to PRRS and simultaneously high growth rate. The identification
of genomic markers involved in actual tolerance will likely prove more difficult, primarily
because tolerance is difficult to quantify and because tolerance mechanism are still poorly
understood. Another avenue of study includes the identification of genomic markers
related to improved response following vaccination.
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INTRODUCTION
Porcine reproductive and respiratory syndrome (PRRS) is the
most economically significant disease impacting commercial pig
production in North America, Europe, and Asia. PRRS was first
described in 1987, followed by characterization of the PRRS
virus (PRRSV) in Europe in 1991, and soon after in the US
(Benfield et al., 1992). Clinical outcomes following infection
include reproductive failure, respiratory disease in young pigs,
and reduced growth performance (Keffaber, 1989; Zimmerman
et al., 2006; Lunney et al., 2010). Perhaps the greatest impact is
the maintenance of a relatively long-term subclinical infection
which participates in a variety of polymicrobial syndromes, such
as porcine respiratory disease complex (PRDC) and porcine
circovirus associated disease (PCVAD). In the field, PRRSV con-
tinues to be linked to a variety of new disease syndromes. In
2005, the emergence of porcine high fever disease (PHFD) in
China was linked to a novel PRRSV strain (Tong et al., 2007).
Affected herds experienced high morbidity and in some cases
100% mortality. PHFD PRRSV continues to spread through-
out Southeast Asia and has been linked to the co-infection of
pigs with the Reston ebolavirus (Barrette et al., 2009; Rowland
et al., 2012). A new PRRS virus, called Lena, is associated
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with outbreaks of severe PRRS in Europe (Karniychuk et al.,
2010).
PRRSV is a member of the arterivirus group, which includes
lactate dehydrogenase–elevating virus (LDV) of mice, simian
hemorrhagic fever virus (SHFV), and equine arteritis virus
(EAV). The arteriviruses belong to the family, Arteriviridae,
within the order, Nidoviridales. As a group, the arteriviruses
possess several novel properties related to viral pathogenesis,
including cytopathic replication in macrophages, the capacity to
establish a persistent infection, and cause severe disease (Snijder
and Spaan, 2007). The15.4 kb PRRSVgenome codes for at least 10
open reading frames (ORFs). The virion includes a nucleocapsid
composed of a single nucleocapsid (N) protein. The viral enve-
lope is dominated by the major glycoprotein, GP5, and the matrix
(M) protein. Minor outer proteins include GP2, GP3, and GP4,
along with two small proteins, E and ORF5 (Johnson et al., 2011).
PRRSV is divided into European and North American genotypes,
designated as type 1 and type 2, respectively. Even though type
1 and type 2 viruses were recognized almost simultaneously on
the continents of North America and Europe and produce similar
clinical signs, the two genotypes possess only about 70% iden-
tity at the nucleotide level. Nucleotide sequence diversity within
each genotypic group can be as much as 10%. During the mid-
1990s, viruses of type 2 origin were introduced into Europe. In
1999, type 1 viruses first appeared in North America (Fang et al.,
2007).
The various clinical outcomes following PRRSV infection are
a consequence of a complex set of interactions between the virus
and the pig host. Following infection, viremia in young pigs con-
tinues for ∼28 days. During this time, the virus primarily targets
macrophages in the lung. The inflammatory response result-
ing from the infection and removal of alveolar macrophages is
responsible for the onset of acute respiratory signs. Following the
disappearance of virus from the blood, virus replication contin-
ues within monocyte/macrophage cells in the lymphoid tissues,
including tonsils and lymph nodes (Rowland et al., 2003). Virus
can be isolated from lymph nodes for more than 100 days after
infection and persistently infect pigs is easily transmit virus to
naïve pigs, likely via shedding from tonsils. Virus replication
in the host gradually decays until the virus becomes extinct, at
around 200 days after infection (Horter et al., 2001; Rowland
et al., 2003). The mechanism for virus extinction is not clear, but
likely relates to the gradual disappearance of PRRSV-permissive
cells combined with a partially effective immune response; e.g.,
low levels of circulating neutralizing antibody. By definition,
PRRSV is not a “persistent” virus, but since the typical lifespan of
a commercial production pig is approximately 180 days, PRRSV
infection is considered to be “life-long.”
The mechanistic basis for maintaining a life-long infection is
dependent on a variety of factors, including; (1) a complex virion
structure dominated by heavily glycosylated surface proteins, (2)
the re-direction of the humoral response toward non-surface pro-
teins, such as N and a variety of non-structural proteins, (3)
antigenic and genetic drift within structural and non-structural
genes, and (4) subversion of innate responses (Chand et al.,
2012). Modified-live virus (MLV) and inactivated virus are the
two principal approaches for PRRS vaccination. At least 20 PRRS
vaccines are commercially available, worldwide. In general, inac-
tivated virus vaccines are not effective. MLV vaccines are effective
in protecting the pig from challenge with a genetically similar
or “homologous” virus, but provide little protection against het-
erologous (genetically diverse) PRRSV isolates (Huang andMeng,
2010; Murtaugh and Genzow, 2011). The purpose of this review
is to provide an overview of experimental models of PRRS infec-
tion, including the phenotypic properties of resistant and tolerant
pigs. For the purpose of this review, PRRS “resistance” is defined
as the ability of a host to limit pathogen burden, e.g., by inhibit-
ing pathogen entry or restricting reproduction of the pathogen
within the host and includes all mechanisms that limit the host
pathogen burden. “Tolerance” is defined as the ability of a host
to limit the detrimental impact of a given pathogen burden on
the host’s performance without directly affecting pathogen bur-
den. Furthermore, for the purpose of this review, the definition
includes the ability to maintain homeostasis in the presence of a
replicating pathogen, with limited ensuing pathology.
THE ROLE OF THE HOST GENOME IN RESPONSE TO PRRSV
INFECTION
Since the discovery of the PRRS virus, there has emerged a body
of evidence associating host genetics with different outcomes fol-
lowing PRRSV infection. In 1998, Halbur et al. evaluated PRRSV
infection in a variety of pig breeds and reported more PRRS-
associated lung lesions in Hampshire pigs. On the reproductive
side, Lowe et al. (2005) concluded that genetics influenced abor-
tion rates in PRRSV-infected Sows. Using an in vitro approach,
Vincent et al. (2006) reported that macrophage responses were
partially predictive of breeds with increased PRRSV resistance.
Petry et al. (2005) found that, compared to a Hampshire/Duroc
line, a Large White/Landrace line showed reduced viremia when
infected with PRRSV. In later work, the same group (Petry et al.,
2007) found that pigs with lower viremia possessed higher levels
of serum interleukin-8 prior to infection. Previous estimates of
heritability of PRRSV resistance are scarce, but heritability esti-
mates for the effect of PRRSV infection on the percentage of live
pigs born to infected sows range from 0.12 to 0.15 (Lewis et al.,
2009). A recent review by Lunney and Chen (2010) describes the
latest progress on the genetics of disease resistance, including the
application of new tools such as the 60K SNP chip for performing
genome-wide association studies (GWASs).
Studies related to understanding the genetic basis for PRRSV
tolerance are non-existent. However, previous studies have shown
that the detrimental impact of PRRSV infection on growth varies
between and within lines and breeds (Greiner et al., 2000; Petry
et al., 2005; Doeschl-Wilson et al., 2009), which may be consid-
ered as indication that genetic variation in tolerance exists.
A good example of tolerance is found in another arterivirus,
LDV. Within 24 h after infection of a mouse, LDV infection lev-
els in the blood approach 1010 virus particles per ml; however,
there are no clinical signs of infection. Viremia decreases to about
107 virus particles and remains at that level for the remainder
of the mouse’s life (Plagemann et al., 1995). The only evi-
dence of infection is increased circulating lactate dehydrogenase
(LDH), the result of a targeted elimination of a subpopulation
of LDH-scavenging macrophages by LDV. The virus does not
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target the macrophage precursor; therefore, the level of LDV
is maintained at a steady state depending on the production
of new LDV-permissive macrophages. Normally, macrophages
would be protected by the presence of virus-specific neutraliz-
ing antibody. Similar to PRRSV, the LDV-specific neutralizing
antibody response is relatively weak, a consequence of a complex
virion structure, including large quantities of surface protein gly-
cosylation. Since the mouse does not become immunocompetent
until after birth, mice can be made immunologically tolerant to
LDV, by infecting neonates within 24 h after birth. The outcome
of neonatal infection is the absence of a LDV-specific antibody
response, a demonstration of immunological tolerance. However,
in mice made immunologically tolerant to LDV, there is no alter-
ation in the level of virus in the blood and no change in the course
of viremia. Furthermore, the immunologically tolerant mice do
not exhibit clinical disease signs (Rowland et al., 1994). Therefore,
mice are “tolerant” to LDV infection. Tolerance to LDV infection
is a mechanism that has the least impact on evolutionary fitness of
the host. In a similar manner, a PRRSV tolerant pig would likely
possess a relatively high virus load, but would show no pathol-
ogy or clinical signs related to disease, including little reduction in
growth or reproductive traits. In the real world, a PRRS tolerant
pig would be particularly beneficial in high-density pig growing
regions where PRRS is endemic and difficult to control. However,
one unintended consequence of a pig showing tolerance would
be the continuous shedding of virus, an efficient mechanism for
spreading virus to naïve pigs.
In 2007, it was generally recognized by commodity groups,
industry, and scientific communities that the next generation of
improved PRRS vaccines was still years away and that genetic
improvement offered a logical solution. In response, the National
Pork Board supported the formation of the PRRS Host Genetics
Consortium (PHGC). The PHGC was formed as a mechanism
for conducting the scientific research necessary to elucidate the
role of the host genome in the response of pigs to PRRSV infec-
tion. The ultimate goal is to find genomic markers that can be
employed in the development of breeding programs to lessen
the impact of PRRSV on the commercial pig industry. Genetic
improvement does not offer a single “magic bullet” solution, but
would be an integral component of other disease management
strategies. For example, identification of genomic markers asso-
ciated with enhanced protection after vaccination could be used
to select for, and, so-called “vaccine-ready” pigs. As discussed
above, pigs tolerant to PRRSV infection would offer a solution
for regions with high pig densities where disease control is diffi-
cult. And finally, markers associated with susceptibility to disease
would be useful to avoid the unintended consequences that can
occur when breeding pigs for other desirable traits.
EXPERIMENTAL MODELS FOR INVESTIGATING THE ROLE OF
THE HOST GENOME IN RESPONSES TO PRRSV INFECTION
For livestock species, investigating the association between
genomic markers and the host response to infection typically
incorporates hundreds, if not thousands, of infected animals.
In the field, these numbers are readily achieved on affected
farms by collecting phenotypic data, such as virus infection sta-
tus (infected versus not infected animals), morbidity/mortality,
and the presence or absence of clinical signs. Even though field
data are highly relevant, assessing phenotypic traits associated
with PRRSV infection can be complicated by several factors. For
instance, obtaining only a single measure of infection status can-
not be used to establish when the pig was first exposed or whether
the infection is acute or chronic. Furthermore, the presence of
other pathogens circulating within the population can mimic or
mask PRRS clinical signs. For example, infection by influenza
virus can mimic PRRSV respiratory clinical signs. Other com-
plicating factors include the unknown properties of a particular
PRRSV field isolate, the contribution of the environmental factors
and overall health status.
The use of experimental infection models can eliminate or
minimize the shortcomings of field studies. For instance, per-
forming repeated phenotypic measurements following experi-
mental challenge with a defined virus can yield reproducible and
accurate determinations of virus-related traits, such as virus load,
peak viremia, and viral clearance from the blood. Disease-related
impacts on growth and performance can also be accurately mea-
sured. Other factors, such as nutrition and environment can be
easily controlled. However, there are important considerations
when performing experimental studies. For example, achieving
the desired number of animals can be expensive. Another con-
sideration is that experimentally infected animals maintained
under “pristine” environmental conditions do not reproduce the
environment found on the typical farm. Therefore, a particu-
lar experimental model may not reflect the response of animals
maintained in the field.
Models that reproduce the effect of PRRSV on pregnant sows
have been described in the literature (Rowland et al., 2003;
Rowland, 2010). Measurable outcomes include the number of
abortions or dead pigs. However, conducting pregnant sow stud-
ies on a large scale can be complex and prohibitively expensive.
Another experimental PRRS model, often described in the liter-
ature measures the impact of PRRSV infection on the severity
of respiratory disease in young pigs. Phenotypic disease traits
include measurements of lung lesions scores and the amount
of virus in alveolar macrophages, obtained by lung lavage. Pigs
are experimentally infected and lungs removed between 7 and
15 days after infection. Phenotypic disease traits, such as lung
lesions scores are obtained post-mortem. One limitation to this
approach is the subjective nature for assessing lung pathology,
which requires a pathologist or other trained professional to make
the lung lesion determinations. Furthermore, different observers
can obtain different disease scores for the same animal. The ter-
minal nature of the experimental model prevents the collection
of repeated measurements of lung lesion development and the
resolution in the same pig.
The model developed by the PHGC incorporates a nursery
pig model, described in Boddicker et al. (2012). High-health
pigs are obtained from crossbred commercial lines with com-
plete parentage and pedigree records. Pigs are negative for PRRSV,
Mycoplasma hyopneumoniae, swine influenza virus (SIV), and
porcine circovirus type 2 (PCV2). Each challenge trial group
is comprised of a population of 200 pigs from at least 30 lit-
ters (six pigs per litter), which are derived from a minimum of
10 sires mated with 3–8 dams/sire. There is no pre-selection of
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sires or dams for any PRRS-related trait. Piglets and parents are
genotyped for>60,000 single-nucleotide polymorphisms (SNPs)
using the Porcine SNP60 BeadChip (Illumina). All phenotypic
and genotypic data are stored and made available to the PHGC
membership through a secure relational database (http://www.
animalgenome.org/lunney/index.php).
Pigs, at 3–4 weeks of age, are challenged with a well-
characterized PRRSV isolate. Infection and disease-related phe-
notypic traits are collected for 42 days after infection. The 42
day period covers both the acute and early persistent stages of
PRRSV infection. For the purpose of definition, virus recovered
from tonsil or other lymphoid tissues at 42 days of infection is
the result of “persistence.” Virus load and weight gain are the two
principal quantitative phenotypic traits measured, each reflect-
ing important aspects of PRRSV infection. Virus load relates to
amount of virus replication and reflects the potential for a pig to
spread virus. Virus load is measured as the area under the curve of
viremia measurements taken over the first 21 days after infection.
Weight gain is used as measurement of the impact of that PRRSV
infection has on growth performance. Both traits are quantifiable,
easily reproducible, and do not require a high level of expertise
to measure. Additional phenotypic data includemeasurements of
innate and adaptive immunity, mortality, and the amount of virus
in tonsil at 42 days.
PHENOTYPIC RESPONSES TO PRRSV INFECTION
The course of viremia and weight gain after experimental PRRSV
infection are described by Boddicker et al. (2012). Figure 1 shows
an example of PRRSV RT-PCR results for 166 pigs in a sin-
gle experimental infection trial. In this example, viremia peaked
between 7 and 14 days after infection and then declined. As
expected, by 28 days post-infection, serum virus declined to
undetectable levels in most pigs. However, in a subpopulation
consisting of ∼10–20% of pigs, circulating virus reappeared.
FIGURE 1 | Viremia following PRRSV infection. Viremia was measured
by RT-PCR of viral RNA using a commercial diagnostic PRRSV assay. For the
purpose of standardization, the results were reported as number of PRRSV
templates per 50ul PCR reaction. Results are shown for those pigs in a
single 200 pig trial that possessed data for all days.
Virus rebound following PRRSV infection is a phenomenon pre-
viously reported by Reiner et al. (2010). The mechanism for virus
rebound is unclear, but could represent the emergence of immune
escape variants.
Pigs in the PHGC model showed a wide variation in weight
gain, with some pigs gaining weight at a relatively normal rate,
while others failed to thrive during the 42 day infection period
(Figure 2). One hypothesis is that pigs that gain weight nor-
mally are the best at controlling virus infection. To address
this possibility, a plot showing weight gain versus virus load
is presented in Figure 3. The pigs falling at each of the four
FIGURE 2 | Weight gain during PRRSV infection. Panel (A) shows the
weight gain for individual infected pigs for 42 days. Panel (B) shows the
weight distribution at 42 days after infection for the same pigs in panel (A).
Black squares represent non-infected reference pigs.
FIGURE 3 | Virus load versus weight gain. The figure shows results for a
single trial. The virus load was calculated as the area under the curve for
viremia over the first 21 days for each pig as described in Figure 1. Average
daily gain was calculated as the weight at 42 days after infection minus the
weight on the day of virus challenge divided by 42 days. Key: Hv, high virus
load; Lv, low virus load; Hg, high weight gain; Lg, low weight gain. Virus
load for each pig was determined by calculating the area under the curve
for the first 21 days after infection.
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extremes of the scatter plot can be described as: high virus/low
weight gain (Hv/Lg), high virus/high weight gain (Hv/Hg), Low
virus/Low weight gain (Lv/Lg), Low virus/High gain (Lv/Hg).
Approximately 10% of pigs fall into each of the extreme groups.
Pigs in the Lv/Hg group can be described as “resistant” to the
effects of PRRSV; whereas, Hv/Lg pigs are sensitive to infection.
Pigs in the Hv/Hg qroup provide the best evidence for a subgroup
of pigs that may be considered as “PRRSV tolerant,” i.e., retain
normal growth in the presence of a relatively high virus load.
However, caution is advised in the interpretation of the results as
high growth rates alone are not necessarily reliable indicators of
tolerance. In order to obtain unbiased tolerance estimates growth
rate measures of the same pigs both infected and in the absence
of the infection would need to be integrated into the appropri-
ate statistical framework (e.g., Kause, 2011; Doeschl-Wilson et al.,
2012).
GENOMIC MARKERS RELATED TO WEIGHT GAIN
AND VIRUS LOAD
To date, 11 groups of 200 pigs from seven genetic sources have
been evaluated under the PHGC model. Results for the genetic
analysis of the first 3 groups (PHGC1-3) from a single genetic
source, are reported in Boddicker et al. (2012). The estimated
heritabilities are 0.3 for both viral load and weight gain after
challenge with the PRRSV isolate NVSL 97-7985 (Boddicker
et al., 2012). A GWAS incorporating the 60K SNP chip identi-
fied genomic regions associated with viral load on chromosomes
4 (SSC4) and SSCX regions on chromosomes SSC1, SSC4, SSC7,
and SSC17 were associated with weight gain. Furthermore, both
virus load and weight gain were associated with a single genomic
region in SSC4, which is best represented by a single SNP marker,
WUR10000125 (WUR). The 1Mb region in SSC4, which exhibits
strong linkage disequilibrium, explained 15.7% of the genetic
variance for viral load and 11.2% for weight gain. The estimated
effects for this region were favorably and nearly perfectly corre-
lated; i.e., pigs with low virus load exhibited greater weight gain.
The favorable allele (B) had a frequency of 0.16 within the exper-
imental population of pigs. Although the number of individuals
with the BB genotype was present at a low frequency, the B allele
appeared to be dominant, i.e., pigs with the AB genotype showed
a favorable response compared to AA.
Candidate genes near the WUR SNP include the guanylate-
binding protein (GBP) gene family [reviewed in Vestal and
Jeyaratnam (2011)]. GBPs are induced by cytokines, such as inter-
feron, and are unique in their ability to bind guanylate. In mice,
the family consists of 11 genes. Expression of GBP is associated
with defense against a variety of RNA viruses, including hepati-
tis C virus, vesicular stomatitis virus, and encephalomyocarditis
virus. The mechanism of how GBP might inhibit PRRSV replica-
tion or influence growth are unclear. The marker on SSCX, which
was associated with only virus load, is in the region of CHST7,
another gene with antiviral properties (Nyberg et al., 2004).
The results reported by Boddicker et al. (2012) provide the first
clear evidence for a genomic marker linked to the response of the
host to PRRSV infection and create the possibility to breed pigs
for increased resistance to infection and improved performance.
Unexpectedly, both disease traits converged at a single marker. In
the experimental studies, genotype BB and AB pigs exhibited as
much as 10% greater weight gain compared to the predominant
AA genotype. This benefit is highly significant in an industry that
survives on small profit margins. Future work is directed at deter-
mining if similar differences between AA and BB animals occur
under field conditions as well as the investigation of other markers
associated with disease resistance or tolerance.
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